Literature DB >> 3403035

Absence of maternal antibodies to hepatitis B core antigen and HBV vertical transmission: one case of infection notwithstanding passive-active prophylaxis.

N Gussetti1, G Largaiolli, R D'Elia.   

Abstract

We report the case of a newborn of an HBsAg carrier mother who was infected by vertical transmission and developed a subclinical hepatitis B at four months of age, notwithstanding the passive-active prophylaxis performed right after birth. The mother's HBV marker status was: HBsAg positive, HBeAg positive, anti-HBc IgM positive at low titer, anti-HBc IgG negative, anti-HBs negative, anti-HBe negative. It is assumed that the absence of anti-HBC antibodies might have favoured, perhaps in utero, the HBV infection whose antigenic expression was subsequently delayed by HBIg administered at birth. These findings suggest that the positivity for anti-HBc IgM must be considered an additional marker of maternal infectivity especially in the absence of anti-HBc IgG antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3403035     DOI: 10.1007/bf01644094

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  22 in total

1.  Perinatal transmission of hepatitis B virus: role of maternal HBeAg and anti-HBc IgM.

Authors:  L Y Hwang; M Roggendorf; R P Beasley; F Deinhardt
Journal:  J Med Virol       Date:  1985-03       Impact factor: 2.327

2.  Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.

Authors:  R P Beasley; L Y Hwang; C C Lin; C E Stevens; K Y Wang; T S Sun; F J Hsieh; W Szmuness
Journal:  Lancet       Date:  1981-08-22       Impact factor: 79.321

3.  Transplacental transmission of hepatitis B virus.

Authors:  S K Panda; A Gupta; R Datta; N C Nayak
Journal:  Lancet       Date:  1986-10-18       Impact factor: 79.321

4.  Transplacental transmission of hepatitis B virus.

Authors:  W T London; A P O'Connell
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

5.  Screening of pregnant women and hepatitis B prophylaxis in newborns.

Authors:  A R Zanetti; P Ferroni; E Tanzi; F Bergamini
Journal:  J Virol Methods       Date:  1985-04       Impact factor: 2.014

6.  Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.

Authors:  B J McMahon; W L Alward; D B Hall; W L Heyward; T R Bender; D P Francis; J E Maynard
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

7.  Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization.

Authors:  A Goudeau; K J Lo; P Coursaget; M J Tong; C L Yeh; Y T Tsai; J K Lee; T C Wu; S H Yeh; S D Lee
Journal:  Dev Biol Stand       Date:  1983

8.  Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.

Authors:  R P Beasley; L Y Hwang; G C Lee; C C Lan; C H Roan; F Y Huang; C L Chen
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

9.  Chronic evolution of acute hepatitis type B: prevalence and predictive markers.

Authors:  F Bortolotti; A Bertaggia; C Crivellaro; M Armigliato; A Alberti; P Pontisso; C Chemello; G Realdi
Journal:  Infection       Date:  1986 Mar-Apr       Impact factor: 3.553

10.  Hepatitis B virus antigens made in microbial cells immunise against viral infection.

Authors:  K Murray; S A Bruce; A Hinnen; P Wingfield; P M van Erd; A de Reus; H Schellekens
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  1 in total

Review 1.  Viral hepatitis.

Authors:  G V Gregorio; G Mieli-Vergani; A P Mowat
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.